Toulouse University Hospital
🇫🇷France
Facing Obstacles to RDI (Relative Dose Intensity) Through Telephone Intervention Strategy
Not Applicable
Completed
- Conditions
- Chronic Lymphocytic Leukemia
- Interventions
- Other: Telephone InterventionOther: Usual Practice
- First Posted Date
- 2011-07-13
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 60
- Registration Number
- NCT01393366
- Locations
- 🇫🇷
Centre Hospitalier de la côte basque, Bayonne, France
🇫🇷CHU Purpan, Toulouse, France
🇫🇷CH Saint Jean, Perpignan, France
Efficacy of Premixed Nitrous Oxide and Oxygen in Patient With Out-of-hospital Moderate Acute Pain
Phase 4
Completed
- Conditions
- Acute Pain
- Interventions
- Drug: Premixed 50% nitrous oxide and oxygen (Kalinox)
- First Posted Date
- 2011-05-19
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 60
- Registration Number
- NCT01356745
- Locations
- 🇫🇷
Universty Hospital Toulouse SAMU 31, Toulouse, France
Determination of the 90% Effective Dose of a Sufentanil Bolus in Analgesia During Lateral Decubitus of Mechanically Ventilated Patients
- First Posted Date
- 2011-05-19
- Last Posted Date
- 2017-05-11
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 25
- Registration Number
- NCT01356732
- Locations
- 🇫🇷
Service de réanimation - Hôpital Purpan, Toulouse, France
Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism
Not Applicable
Completed
- Conditions
- Pulmonary Embolism
- First Posted Date
- 2011-03-31
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 165
- Registration Number
- NCT01326507
- Locations
- 🇫🇷
Hôpital Rangueil Service des urgences, Toulouse, France
Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
Phase 4
Completed
- Conditions
- Prader-Willi SyndromeGrowth Hormone Deficiency
- Interventions
- Drug: Growth hormone (Genotonorm® or Omnitrope®)Procedure: biopsyProcedure: DEXA, blood tests, H.G.P.O, osseous age.
- First Posted Date
- 2011-02-17
- Last Posted Date
- 2021-09-24
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 111
- Registration Number
- NCT01298180
- Locations
- 🇫🇷
CHU Nice Hôpital Archet 2 - 151 route Saint Antoine de Ginestière, Nice, France
🇫🇷CHU La Rochelle Service de Pédiatrie - Rue du Dr Schweitzer, La Rochelle, France
🇫🇷CHU Saint-Etienne Hôpital Nord Service de Pédiatrie, Saint-etienne, France
Measurement of High Order Aberrations in Late Stages Keratoconus
Not Applicable
Terminated
- Conditions
- Keratoconus
- Interventions
- Device: classic aberrometer and aberrometer AOVIS-1Device: Aberrometer AOVIS-I
- First Posted Date
- 2011-02-14
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 28
- Registration Number
- NCT01295164
- Locations
- 🇫🇷
University Hopstial Toulouse, Toulouse, France
Evaluation of the Effect of Repetitive Transcranial Magnetic Stimulation in Pain Perception in Parkinson's Disease
Phase 2
Completed
- Conditions
- Parkinson's Disease
- Interventions
- Device: Repetitive Transcranial Magnetic Stimulation
- First Posted Date
- 2011-01-12
- Last Posted Date
- 2013-06-19
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 30
- Registration Number
- NCT01275573
- Locations
- 🇫🇷
Purpan Hospital, Toulouse, France
Gene Therapy of Pancreatic Ductal Adenocarcinoma
Phase 1
Completed
- Conditions
- Pancreatic Adenocarcinoma
- First Posted Date
- 2011-01-11
- Last Posted Date
- 2016-03-14
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 22
- Registration Number
- NCT01274455
- Locations
- 🇫🇷
Toulouse Universitary Hospital (Rangueil), Department of Gastroenterology At Rangueil Hospital, Toulouse, France
Study on the Appropriateness of Bariatric Surgery in Adolescents
Terminated
- Conditions
- Morbid Obesity
- Interventions
- Other: feasibility
- First Posted Date
- 2010-11-30
- Last Posted Date
- 2013-11-11
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 10
- Registration Number
- NCT01249950
- Locations
- 🇫🇷
UHToulouse, Toulouse, France
Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine
Phase 1
Completed
- Conditions
- Cardiovascular DiseasesPeripheral Vascular Diseases
- Interventions
- Biological: Expanded autologous ASCs
- First Posted Date
- 2010-09-29
- Last Posted Date
- 2017-05-11
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 13
- Registration Number
- NCT01211028
- Locations
- 🇫🇷
University Hospital of Toulouse, Rangueil, Toulouse, France
© Copyright 2025. All Rights Reserved by MedPath